De Minimis Risk: A Proposal for a New Category of Research Risk

@article{Rhodes2011DeMR,
  title={De Minimis Risk: A Proposal for a New Category of Research Risk},
  author={R. Battin Rhodes and Jody Azzouni and Stefan Bernard Baumrin and Keith J. Benkov and Martin J. Blaser and Barbara L Brenner and Joseph Warren Dauben and William James Earle and Lily Frank and Nada Gligorov and Joseph Goldfarb and Kurt Hirschhorn and Rochelle Hirschhorn and Ian R. Holzman and Debbie Indyk and Ethylin Wang Jabs and Douglas P. Lackey and Daniel A. Moros and Sean Philpott and Matthew E. Rhodes and Lynne D. Richardson and Henry S Sacks and Abraham P. Schwab and Rhoda S. Sperling and Brett E. Trusko and Arnulf Zweig},
  journal={The American Journal of Bioethics},
  year={2011},
  volume={11},
  pages={1 - 7}
}
De Minimis Risk: A Proposal for a New Category of Research Risk Rosamond Rhodes a , Jody Azzouni b , Stefan Bernard Baumrin c , Keith Benkov a , Martin J. Blaser d , Barbara Brenner a , Joseph W. Dauben c , William J. Earle c , Lily Frank c , Nada Gligorov a , Joseph Goldfarb a , Kurt Hirschhorn a , Rochelle Hirschhorn d , Ian Holzman a , Debbie Indyk a , Ethylin Wang Jabs a , Douglas P. Lackey c , Daniel A. Moros a , Sean Philpott e , Matthew E. Rhodes f , Lynne D. Richardson a , Henry S… 
De Minimis Risk Proposal Offers Little to Current Approach
TLDR
This work feels compelled to challenge the basic ethical framework of the de minimis risk proposal, as well as its factual accuracy with respect to current human subjects regulation.
Setting risk thresholds in biomedical research: lessons from the debate about minimal risk
  • A. Rid
  • Psychology, Medicine
    Monash bioethics review
  • 2014
TLDR
There is a need both to better define the existing risk thresholds and to delineate new thresholds in order to develop more risk-adapted systems of research oversight.
Love Thy Neighbor: Replacing Paternalistic Protection as the Grounds for Research Ethics
  • R. Rhodes
  • Medicine
    The American journal of bioethics : AJOB
  • 2015
TLDR
In a broad sense, I agree with the conclusions of the target article by Christine Grady and colleagues (2015), “Broad Consent for Research with Biological Samples: Workshop Conclusions”, but the proposal in favor of accepting “process consent” lacks a framework that explains and justifies the group’s suggestions.
A decision tool to guide the ethics review of a challenging breed of emerging genomic projects
TLDR
A novel two-step decision tool for researchers and policymakers, which uses traditional criteria to sort clearly defined activities while requiring the use of actual risk levels to decide more complex cases is synthesized.
How should we regulate risk in biomedical research? An ethical analysis of recent policy proposals and initiatives.
  • A. Rid
  • Medicine
    Health policy
  • 2014
TLDR
The present paper offers the first systematic overview and ethical analysis of how European and U.S. regulators approach the development of more risk-adapted regulations and finds that so-called stratified approaches are ethically preferable because they specify risk categories with corresponding subject protections, and thereby reduce unwarranted variation in how research participants are protected in different studies.
Promoting Research with Organ Transplant Patients.
TLDR
It is argued that all transplant candidates should be invited and encouraged to participate in research and that early discussion with patients about participating in research may help to overcome reluctance about and the ethical challenges of transplantation research with human subjects.
De Minimis Normativism: a New Theory of Full Aptness
Full aptness is the most important concept in performance-based virtue epistemology. The structure of full aptness, in epistemology and elsewhere, is bilevelled. At the first level, we evaluate
A discipline-relevant conceptual framework for research ethics review in economic sciences
Abstract This article aims to contribute to the discourse on the growing frustration amongst researchers about compulsory institutional research ethics review. The question that directs this article
A human rights approach to an international code of conduct for genomic and clinical data sharing
TLDR
This article proposes that an international code of conduct be designed to enable global genomic and clinical data sharing for biomedical research and proposes to position it within a human rights framework.
Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
TLDR
Apparent benefits of the combination between early detection and early pharmacological approaches for COVID-19 demonstrated to be consistent when when compared to different control groups of untreated patients, and could allow a large number of patients prevented from hospitalizations, deaths and persistent symptoms after CO VID-19 remission.
...
1
2
3
...

References

SHOWING 1-10 OF 48 REFERENCES
Privacy Overkill
TLDR
Mark Rothstein concludes that “utilitarian concerns about burdens on research are insufficient to justify dispensing with any consideration of the possible effects of the research on the individuals from whom the information and specimens are obtained” (3).
Urge Overkill: Protecting Deidentified Human Subjects at What Price?
  • M. Angrist
  • Medicine
    The American journal of bioethics : AJOB
  • 2010
The problem for both parties, as Greely (2007) has eloquently described it, is twofold: (1) Deidentification is an increasingly difficult, if not impossible, trick to pull off in human subjects
Health Insurance Portability Accountability Act (HIPAA) Regulations: Effect on Medical Record Research
TLDR
HIPAA appears to inhibit medical record and database research, and current HIPAA implementation strategies increase workload for HSC and researchers, and increase the dropout rate for proposed studies when investigators are unable or unwilling to meet the regulatory requirements.
Brief Research Report: Certificates of Confidentiality Under the Public Health Service Act: Strong Protection but Not Enough
TLDR
It is argued that participants in research should be entitled to an absolute privilege against disciosure of their data to protect privacy and to warn them in advance of any material risks that may result from uninkmkd didosure of sensitive dm to third @a.
Grinding to a halt: the effects of the increasing regulatory burden on research and quality improvement efforts.
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2009
TLDR
5 problem areas are identified that excessive regulatory oversight is seriously affecting translational research and quality improvement efforts and relatively simple steps could improve regulatory oversight in these problem areas.
Protecting Medical Record Information: Start Your Research Registries Today
TLDR
The present study quantifies the cost of HIPAA compliance to maintain access to faculty's career‐long clinical activities and stresses the importance of research registries as a means of protecting their own career's work.
The Recipe for Overreaching Regulation
  • A. Schwab
  • Political Science, Medicine
    The American journal of bioethics : AJOB
  • 2010
TLDR
Three features of the federal regulations and their application that produce institutional review boards’ tendency toward over-reaching regulation are identified: too broad, ambiguous and vague language, and a protectionist attitude.
Oversight of Human Participants Research: Identifying Problems To Evaluate Reform Proposals
TLDR
To inform public deliberation on the research oversight system, 15 current problems are identified and grouped them into 3 broad categories and critically assess proposed reforms according to their relevance to these specific problems.
Surrogate consent for research involving adults with impaired decision making: Survey of Institutional Review Board practices
TLDR
Much variability exists in Institutional Review Board surrogate consent practices and limits on risks in studies involving incapacitated adults, and this variability may have adverse consequences for needed research involving incapacitate adults.
The Ethics of Using Quality Improvement Methods in Health Care
TLDR
This report discusses deliberate efforts of providers to meet their obligations to improve the quality of patient care through clinical and managerial changes in the processes of care, and presents recommendations for developing policy and practices to protect patients from both the harm that QI activities might cause and the harms that quality and safety deficits do cause.
...
1
2
3
4
5
...